{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:12:23Z","timestamp":1648678343029},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T00:00:00Z","timestamp":1131408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"DOI":"10.1007\/s00120-005-0940-3","type":"journal-article","created":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T14:09:58Z","timestamp":1131372598000},"source":"Crossref","is-referenced-by-count":0,"title":["Die Induratio penis plastica"],"prefix":"10.1007","author":[{"given":"J.","family":"D\u00f6rsam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Djakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,8]]},"reference":[{"key":"940_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0090-4295(94)80155-X","volume":"44","author":"Akkus","year":"1994","unstructured":"Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF (1994) Is colchicine effective in Peyronie\u2019s disease? A Pilot study. Urology 44: 291\u2013295","journal-title":"Urology"},{"key":"940_CR2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1046\/j.1464-410x.2001.02139.x","volume":"87","author":"Brake","year":"2001","unstructured":"Brake M, Loertzer H, Horsch R, Keller H (2001) Treatment of Peyronie\u2019s disease with local interferon-\u03b12b. BJU Int 87: 654\u2013657","journal-title":"BJU Int"},{"key":"940_CR3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-5347(17)47382-4","volume":"134","author":"Carson","year":"1985","unstructured":"Carson CC, Coughlin PWF (1985) Radiation therapy for Peyronie\u2019s disease: Is there a place? J Urol 134: 684\u2013686","journal-title":"J Urol"},{"key":"940_CR4","doi-asserted-by":"crossref","unstructured":"Devine CJ, Somers KD, Jordan GH, Schlossberg SM (1997) Proposal: Trauma as the cause of the Peyronie\u2019s lesion. J Urol: 157(1): 285\u2013290","DOI":"10.1016\/S0022-5347(01)65361-8"},{"key":"940_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365599109024539","volume":"25","author":"Duncan","year":"1991","unstructured":"Duncan MR, Berman B, Nseyo UO (1991) Regulation of the proliferation and biosynthetic activities of cultured human Peyronie\u2019s disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol 25: 89\u201394","journal-title":"Scand J Urol Nephrol"},{"key":"940_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF01576355","volume":"8","author":"Gasior","year":"1990","unstructured":"Gasior BL, Levine FJ, Howannesian A, Krane RJ, Goldstein I (1990) Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie\u2019s disease. A pharmacocavernosometric and pharmacocavernosographic study. World J Urol 8: 90\u201396","journal-title":"World J Urol"},{"key":"940_CR7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","volume":"144","author":"Gelbard","year":"1990","unstructured":"Gelbard MK, Dorey F, James K (1990) The natural history of Peyronie\u2019s disease. J Urol 144: 1376\u20131379","journal-title":"J Urol"},{"key":"940_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","volume":"149","author":"Gelbard","year":"1993","unstructured":"Gelbard MK, James K, Riach P, Dorey F (1993) Collagenase versus placebo in the treatment of Peyronie\u2019s disease: A double-blind study. J Urol 149: 56\u201358","journal-title":"J Urol"},{"key":"940_CR9","first-page":"224","volume":"17","author":"Hasche-Kl","year":"1978","unstructured":"Hasche-Kl\u00fcnder R (1978) Zur Behandlung der Induratio penis plastica mit para-aminobenzoesaurem Kalium (PABK). Urologe A 17: 224\u2013227","journal-title":"Urologe A"},{"key":"940_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-2003-43172","volume":"34","author":"Hauck","year":"2003","unstructured":"Hauck EW, Hauptmann A, Haag SM, Weidner W (2003) Neue Aspekte zur \u00c4tiopathogenese der Induratio penis plastica. Aktuel Urol 34: 387\u2013391","journal-title":"Aktuel Urol"},{"key":"940_CR11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/01.ju.0000108060.30363.8d","volume":"171","author":"Hauck","year":"2004","unstructured":"Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W (2004) Extracorporeal shock wave therapy for Peyronie\u2019s disease: Exploratory meta-ananlysis of clinical trials. J Urol 171: 740\u2013745","journal-title":"J Urol"},{"key":"940_CR12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0090-4295(00)00805-0","volume":"56","author":"Incrocci","year":"2000","unstructured":"Incrocci L, Hop WCJ, Slob AK (2000) Current sexual functioning in 106 patients with Peyronie\u2019s disease treated with radiotherapy 9 years earlier. Urology 56: 1030\u20131034","journal-title":"Urology"},{"key":"940_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1464-410X.1997.02849.x","volume":"79","author":"Judge","year":"1997","unstructured":"Judge IS, Wisniewski ZS (1997) Intralesional interferon in the treatment of Peyronie\u2019s disease. A pilot study. Br J Urol 79: 40\u201342","journal-title":"Br J Urol"},{"key":"940_CR14","first-page":"1075","volume":"68","author":"Kadioglu","year":"2002","unstructured":"Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S (2002) A Retrospective Review of 307 men with Peyronie\u2019s disease. J Urol 68: 1075\u20131079","journal-title":"J Urol"},{"key":"940_CR15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0022-5347(01)64224-1","volume":"158","author":"Levine","year":"1997","unstructured":"Levine LA (1997) Treatment of Peyronie\u2019s disease with intralesional Verapamil injection. J Urol 158:1395\u20131399","journal-title":"J Urol"},{"key":"940_CR16","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","volume":"151","author":"Levine","year":"1994","unstructured":"Levine LA, Merrick PF, Lee RC (1994) Intralesional Verapamil injection for the treatment of Peyronie\u2019s disease. J Urol 151: 1522\u20131524","journal-title":"J Urol"},{"key":"940_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/089277903321196788","volume":"17","author":"Michel","year":"2003","unstructured":"Michel MS, Ptaschnyk T, Musial A, Braun P, Lenz ST, Alken P, K\u00f6hrmann KU (2003) Objective and subjective changes in patients with Peyronie\u2019s disease after management with shockwave therapy. J Endourol 17: 41\u201344","journal-title":"J Endourol"},{"key":"940_CR18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00066-003-1022-3","volume":"179","author":"Pambor","year":"2003","unstructured":"Pambor C, Gademann G (2003) Induratio penis plastica. Strahlenther Onkol 179: 787\u2013790","journal-title":"Strahlenther Onkol"},{"key":"940_CR19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1464-410X.2003.04134.x","volume":"91","author":"Prieto","year":"2003","unstructured":"Prieto Castro RM, Leva Vallejo ME, Reguiero Lopez JC, Anglada Curado FJ, Alvarez Kindelan J, Requena Tapia MJ (2003) Combined treatment with vitamin E and colchicines in the early stages of Peyronie\u2019s disease. BJU Int 91: 522\u2013524","journal-title":"BJU Int"},{"key":"940_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","volume":"16","author":"Safarinejad","year":"2004","unstructured":"Safarinejad MR (2004) Therapeutic effects of colchicine in the management of Peyronie\u2019s disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 16: 238\u2013243","journal-title":"Int J Impot Res"},{"key":"940_CR21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","volume":"88","author":"Schwarzer","year":"2001","unstructured":"Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U (2001) The prevalence of Peyronie\u2019s disease: results of a large survey. BJU Int 88: 727\u2013730","journal-title":"BJU Int"},{"key":"940_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007611-194802000-00017","volume":"41","author":"Scott","year":"1948","unstructured":"Scott WW, Scardino PL (1948) New concept in treatment of Peyronie\u2019s disease. South Med J 41: 173\u2013176","journal-title":"South Med J"},{"key":"940_CR23","first-page":"61","volume":"9","author":"Shah","year":"1983","unstructured":"Shah PJR, Green NA, Adib RS et al. (1983) A multicentre double-blind controlled clinical trial of potassium paraaminobenzoat (Potaba) in Peyronie\u2019s disease. Prog Reprod Biol Med 9: 61\u201367","journal-title":"Prog Reprod Biol Med"},{"key":"940_CR24","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","volume":"162","author":"Teloken","year":"1999","unstructured":"Teloken C, Rhoden EL, Grazziotin TM, Da Ros CT, Sogari PR, Souto CAV (1999) Tamoxifen versus placebo in the treatment of Peyronie\u2019s disease. J Urol 162: 2003\u20132005","journal-title":"J Urol"},{"key":"940_CR25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","volume":"47","author":"Weidner","year":"2005","unstructured":"Weidner W, Hauck EW, Schnitker J, The Peyronie\u2019s Disease Study Group and Andrological Group of the German Urologists (2005) Potassium Paraaminobenzoat (POTABA) in the treatment of Peyronie\u2019s disease: A prospective, placebo-controlled, randomized study. Eur Urol 47: 530\u2013536","journal-title":"Eur Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0940-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-005-0940-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0940-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:58:36Z","timestamp":1558609116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-005-0940-3"}},"subtitle":["Aktuelle medikament\u00f6se und nicht-invasive Therapiem\u00f6glichkeiten"],"short-title":[],"issued":{"date-parts":[[2005,11,8]]},"references-count":25,"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1007\/s00120-005-0940-3","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,8]]}}}